Analyst Ranking
Bottom 8%
#4785 out of 5156 analysts
Average Return
-2.32%
Win Rate
45%41 out of 92
Risk vs Reward
Poor
Good

Brandon Folkes's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Connect Biopharma Holdings LtdCNTB
+170.59%$0.85$2.30
2025-06-11 -
2025-12-18
Buy
Elutia IncELUT
+130.77%$1.43$3.30
2023-08-14 -
2024-08-14
Strong Buy
Trevi Therapeutics IncTRVI
+122.74%$2.77$6.17
2024-06-12 -
2025-06-12
Strong Buy
Cormedix IncCRMD
+118.98%$6.27$13.73
2024-08-25 -
2025-08-25
Strong Buy
Trevi Therapeutics IncTRVI
+94.73%$6.26$12.19
2025-05-27 -
2025-12-18
Buy

Brandon Folkes Analyst Color

Get additional color on Brandon Folkes's coverage of popular stocks

Brandon Folkes's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Milestone Pharmaceuticals IncMIST
3Buy$8.00+284.62%Maintains
5 days ago
Pelthos Therapeutics IncPTHS
1Buy$60.00+164.67%Initiates Coverage On
17 days ago
Traws Pharma IncTRAW
1Buy$8.00+540.00%Initiates Coverage On
17 days ago
Cardiol Therapeutics IncCRDL
2Buy$9.00+791.09%Reiterates
18 days ago
Cormedix IncCRMD
4Buy$18.00+51.01%Maintains
a month ago
Collegium Pharmaceutical IncCOLL
5Buy$46.00-6.75%Maintains
a month ago
Xeris Biopharma Holdings IncXERS
3Buy$10.00+42.65%Maintains
a month ago
Indivior PLCINDV
2Buy$35.00-1.52%Maintains
2 months ago
Rani Therapeutics Holdings IncRANI
3Buy$11.00+623.68%Assumes
2 months ago
Omeros CorpOMER
2Buy$20.00+118.34%Maintains
2 months ago
Mannkind CorpMNKD
6Buy$11.00+84.25%Reiterates
2 months ago
Genfit SaGNFTY
2Buy$7.00+44.33%Maintains
3 months ago
Rein Therapeutics IncRNTX
1Buy$10.00+675.19%Initiates Coverage On
3 months ago
Ani Pharmaceuticals IncANIP
5Buy$121.00+46.08%Maintains
3 months ago
Valneva SeVALN
2Buy$18.00+121.13%Reiterates
4 months ago
Journey Medical CorpDERM
2Buy$13.00+64.14%Initiates Coverage On
4 months ago
Achieve Life Sciences IncACHV
2Buy$12.00+176.50%Initiates Coverage On
4 months ago
Eupraxia Pharmaceuticals IncEPRX
3Buy$12.00+92.00%Reiterates
4 months ago
Polypid LtdPYPD
4Buy$13.00+231.63%Reiterates
4 months ago
Connect Biopharma Holdings LtdCNTB
2Buy$7.00+204.35%Reiterates
4 months ago
Sagimet Biosciences IncSGMT
1Buy$29.00+386.58%Assumes
4 months ago
Enanta Pharmaceuticals IncENTA
1Buy$20.00+37.65%Assumes
5 months ago
Zevra Therapeutics IncZVRA
1Buy$26.00+220.99%Initiates Coverage On
6 months ago
Heron Therapeutics IncHRTX
2Buy$6.00+365.12%Initiates Coverage On
6 months ago
Trevi Therapeutics IncTRVI
2Buy$21.00+72.27%Initiates Coverage On
7 months ago
Rockwell Medical IncRMTI
1Strong Buy$5.00N/AInitiates Coverage On
a year ago
Adial Pharmaceuticals IncADIL
1Strong Buy$8.00N/AInitiates Coverage On
a year ago
Emergent Biosolutions IncEBS
4Strong Buy$16.00N/AReiterates
a year ago
Scilex Holding CoSCLX
1Strong Buy$455.00N/AInitiates Coverage On
2 years ago
Sanara Medtech IncSMTI
4Strong Buy$59.00N/AReiterates
2 years ago
Jazz Pharmaceuticals PLCJAZZ
2Strong Buy$180.00N/AReiterates
2 years ago
Elutia IncELUT
3Strong Buy$8.00N/AReiterates
2 years ago
Amryt Pharma PLCAMYT
2Hold$14.75N/ADowngrades
3 years ago
Veru IncVERU
3Strong Buy$220.00N/AMaintains
3 years ago
Sorrento Therapeutics IncSRNEQ
1Strong Buy$5.00N/AInitiates Coverage On
3 years ago
Obseva SaOBSVF
1Strong Buy$6.00N/AInitiates Coverage On
4 years ago
Alkermes PLCALKS
1Strong Buy$32.00N/AUpgrades
4 years ago
IMV IncIMVIQ
1Strong Buy$40.00N/AInitiates Coverage On
4 years ago
Redhill Biopharma LtdRDHL
1Strong Buy$22,000.00N/AInitiates Coverage On
4 years ago
Trevena IncTRVN
1Strong Buy$3,125.00N/AInitiates Coverage On
5 years ago
Optinose IncOPTN
3Strong Buy$315.00N/AReiterates
6 years ago
Eagle Pharmaceuticals IncEGRX
2Hold$46.00N/AMaintains
6 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$30.00N/AReiterates
6 years ago
Opiant Pharmaceuticals IncOPNT
1Strong Buy$42.00N/AMaintains
7 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Strong Buy$50.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.